Mizuho Trust & Banking’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-10,510,663
Closed -$338M 497
2016
Q3
$338M Sell
10,510,663
-185,861
-2% -$6.21M 1% 16
2016
Q2
$357M Buy
10,696,524
+94,746
+0.9% +$3.02M 1.1% 14
2016
Q1
$298M Buy
10,601,778
+392,170
+4% +$11.2M 0.94% 17
2015
Q4
$317M Sell
10,209,608
-40,670
-0.4% -$1.28M 1.04% 15
2015
Q3
$305M Buy
10,250,278
+400,859
+4% +$12.9M 1.06% 11
2015
Q2
$313M Buy
9,849,419
+234,188
+2% +$7.63M 1.04% 11
2015
Q1
$317M Buy
9,615,231
+378,185
+4% +$12M 1.08% 11
2014
Q4
$273M Buy
9,237,046
+439,289
+5% +$12.6M 0.96% 13
2014
Q3
$247M Sell
8,797,757
-578,976
-6% -$16.2M 0.93% 14
2014
Q2
$264M Sell
9,376,733
-197,444
-2% -$5.63M 0.94% 14
2014
Q1
$292M Sell
9,574,177
-193,256
-2% -$5.76M 1.09% 12
2013
Q4
$287M Sell
9,767,433
-512,945
-5% -$14.9M 1.09% 12
2013
Q3
$273M Hold
10,280,378
1.14% 14
2013
Q2
$273M Buy
+10,280,378
New +$284M 1.15% 14

Other funds holding PFE

Mizuho Trust & Banking's PFE Position: Q4 2016 in Review

Mizuho Trust & Banking sold out of Pfizer (PFE) in Q4 2016, closing a stake of 10,510,663 shares — an estimated $338M sold.

Mizuho Trust & Banking first reported a position in PFE in Q2 2013 and held it in 14 quarters. The position peaked at $357M in Q2 2016. 2,059 funds tracked by Wall St. Rank hold PFE as of Q4 2016.

  • Mizuho Trust & Banking reported no remaining Pfizer position as of Q4 2016 after selling out during the quarter.
  • Mizuho Trust & Banking sold 10,510,663 Pfizer shares in Q4 2016, an estimated $338M.
  • Mizuho Trust & Banking first reported a position in Pfizer in Q2 2013 and held it in 14 quarters.
  • Mizuho Trust & Banking's Pfizer position peaked at $357M in Q2 2016.
  • 2,059 funds tracked by Wall St. Rank held Pfizer as of Q4 2016.

Based on Mizuho Trust & Banking's 13F filing for Q4 2016, filed 14 Feb 2017.